ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 248 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q2 2022. The put-call ratio across all filers is 52.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,479,984 | +100.5% | 3,765,600 | +92.3% | 0.14% | +97.3% |
| Q2 2023 | $24,678,851 | +12843.8% | 1,958,639 | +13306.2% | 0.07% | +7200.0% |
| Q1 2023 | $190,661 | -97.3% | 14,610 | -96.4% | 0.00% | -95.8% |
| Q4 2022 | $7,089,516 | -52.5% | 401,900 | -59.0% | 0.02% | -60.0% |
| Q3 2022 | $14,935,000 | -19.6% | 980,600 | -21.7% | 0.06% | -23.1% |
| Q2 2022 | $18,578,000 | +1308.5% | 1,252,700 | +832.1% | 0.08% | +1014.3% |
| Q4 2019 | $1,319,000 | +265.4% | 134,400 | +308.5% | 0.01% | +250.0% |
| Q3 2019 | $361,000 | -66.4% | 32,900 | -70.8% | 0.00% | -60.0% |
| Q1 2019 | $1,073,000 | -62.4% | 112,495 | -43.8% | 0.01% | -58.3% |
| Q3 2018 | $2,850,000 | -59.9% | 200,000 | -64.1% | 0.01% | -70.0% |
| Q2 2017 | $7,107,000 | +55.1% | 557,000 | +60.1% | 0.04% | +25.0% |
| Q3 2016 | $4,582,000 | -67.5% | 347,900 | -70.5% | 0.03% | -66.7% |
| Q1 2015 | $14,083,000 | – | 1,177,500 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 875,000 | $13,138,000 | 2.70% |
| KESTREL INVESTMENT MANAGEMENT CORP | 417,400 | $6,267,000 | 2.63% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 16,933,530 | $127,255,604,000 | 2.31% |
| Adirondack Research & Management Inc. | 123,148 | $1,849,000 | 2.19% |
| Smith, Graham & Co., Investment Advisors, LP | 966,216 | $14,508,000 | 1.18% |
| Lombard Odier Asset Management (Switzerland) SA | 839,521 | $12,605,000 | 0.84% |
| HENNESSY ADVISORS INC | 946,800 | $14,216,000 | 0.83% |
| Waterfront Wealth Inc. | 95,403 | $1,464,000 | 0.74% |
| Arjuna Capital | 84,697 | $1,272,000 | 0.62% |
| SummerHaven Investment Management, LLC | 62,844 | $944,000 | 0.58% |